Del. Judge OKs KaloBios Ch. 11 Disclosure, Investor Pact
KaloBios Pharmaceuticals, formerly helmed by indicted CEO Martin Shkreli, won approval for its Chapter 11 disclosure and schedule Friday, after approval of a settlement with prepetition equity buyers and the temporary...To view the full article, register now.
Already a subscriber? Click here to view full article